Navigation Links
Perrigo Announces Approval for Over-the-Counter Children's Cetirizine Oral Solution
Date:4/14/2008

ALLEGAN, Mich., April 14 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Children's Cetirizine Hydrochloride Oral Solution (Allergy) and Children's Cetirizine Hydrochloride Oral Solution (Hives-Relief), 1mg/mL.

The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare's Children's Zyrtec(R) Oral Solution, 1mg/mL, indicated for indoor and outdoor allergy and hives relief. According to Wolters Kluwer data, brand sales for the original prescription strength version of the product for the last 12 months ending December 2007 were approximately $80 million.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This approval reflects our strategy to be first to market with the important products that make quality healthcare more affordable for our customers."

The Company expects to begin shipping the product immediately.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of th
'/>"/>

SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015   The New York Times ... internationally acclaimed plastic surgeon, Dr. Rod Rohrich . ... is proven to reduce fat deposits under the chin. ... The active ingredient in Kybella, deoxycholic acid, dissolves ... the ability to reshape this area without surgery. "So ...
(Date:5/4/2015)... , May 4, 2015 Former NASA ... News online last week where he discussed Theradome™, the ... be FDA-cleared. The FOX segment shows firsthand how, via ... affordable hair loss solution that will not require surgery ... the mitochondria at the base of the hair follicle, ...
(Date:5/4/2015)... Conn. , May 4, 2015 /PRNewswire/ ... market private equity firm, announced today that ... portfolio company, BioPharm Communications. BioPharm specializes in the ... programs for the pharmaceutical and biotechnology industries. ... repaid to its shareholders half of their ...
Breaking Medicine Technology:Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... , ST. LOUIS , ... today announced that it will broadcast its fourth quarter earnings results ... Thursday, February 4, 2010 at 11:00 a.m. Central Time ... through InterCall at http://tinyurl.com/yi4q09 .  Access to the live audio ...
... , RICHMOND, Calif. , Jan. 27 ... the company will release its fourth quarter and full year 2009 financial ... The press release will be followed by a conference call at ... telephone and webcast. During the conference call, the company will review the ...
Cached Medicine Technology:Young Innovations, Inc. Provides 4th Quarter Conference Call Details 2Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast 2
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released an update ... in coverage and reimbursement, and physician practice standards and ... Reports last September, many state regulating bodies responded by ... delivery in their state,” said Jonathan Linkous, CEO of ... nation, ATA reevaluated the indicators for each state and ...
(Date:5/4/2015)... 2015 METTLER TOLEDO has announced ... Data Integrity in a GXP Regulated Laboratory ", ... This webinar will be presented on May 27, ... integrity is a critical component of pharmaceutical product ... However, in recent years an increasing number of ...
(Date:5/4/2015)... Washington, DC (PRWEB) May 04, 2015 ... of Kit Check as a finalist for the EY ... Washington Region. The awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ... finalist by a panel of independent judges. Award ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Columbia, South Carolina. Fans of Paul McCartney have ... tour which originally kicked off in 2013. The most visited ... the legendary performer recently announced that he would be adding ... June 21st, in Charlottesville, VA at John Paul Jones Arena ...
(Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... hosted a ribbon cutting ceremony at their brand new, ... of this year. The new building will not only ... patient population, but will also offer community and educational ... , The new facility is located next door to ...
Breaking Medicine News(10 mins):Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... Oct. 28 A few spaces remain for the ... Symposium on Nov. 4-5, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... writers and journalists and will focus on how FDA ... , This year,s symposium will feature an address by ...
... 28 If we get a boo-boo, we might know to ... kiss it and make it all better. But, what if ... us who aren,t prepared for dental emergencies can quickly get back ... Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , Medialink ...
... Oct. 28 Collagen Matrix, Inc., the leader in ... Shu-Tung Li, the Company,s Founder, President, and Chief Executive ... Executive of the Year category of the 2009 New ... Politziner and Mattia, Certified Public Accountants and Consultants. ...
... Inc . (Pink Sheets: JEDM) ( www.jedimindinc.com ) ... excellent cash position to expand both the gaming and medical divisions ... in excess of $500,000 of working capital which is being used ... computer hardware and software applications to the latest standards. , ...
... Research Foundation (LRF) is pleased to announce that David ... Thomas Kipps, MD, PhD, Moores Cancer Center, University of ... round of funding under the Foundation,s Chronic Lymphocytic Leukemia ... Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are ...
... and mental health in study , WEDNESDAY, Oct. 28 ... the emotional and mental well-being of breast cancer patients, ... 130 patients at Saint Joseph Hospital in Chicago, aged ... meditation group or to a usual care control group. ...
Cached Medicine News:Health News:Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest Growing Companies 2Health News:Jedi Mind, Inc. in Excellent Financial Shape to Expand Business 2Health News:Lymphoma Research Foundation announces recipients of CLL/SLL Research Initiative grants 2Health News:Meditation May Reduce Stress in Breast Cancer Patients 2
... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
... and quantitative evaluation of pancreatic b-cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... to assess b-cell function because of the ...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
... quantitative evaluation of pancreatic -cell function is not ... study of the natural history of diabetes mellitus, ... a guide to the correct choice of treatment. ... -cell function because of the large and variable ...
Medicine Products: